iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionCresset Asset Management, LLC
Latest Disclosed Ownership12,181 shares
Latest Disclosed Value $ 2,056,842
Cresset Asset Management, LLC reports 30.00% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Cresset Asset Management, LLC filed a 13F-HR form disclosing ownership of 12,181 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $2,056,842 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 9,370 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 30.00% during the quarter. The current value of the position is $1,596,320 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,181 2,811 30.00 2,057 30.04 0.0089
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,370 483 5.43 1,581 23.32 0.0067
2026-01-22 2025-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 8,887 102 1.16 1,283 15.39 0.0056
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,901 2,116 1,574 0.0059
2026-01-22 2025-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 8,785 -1,842 -17.33 1,111 -18.25 0.0055
2025-08-13 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,644 17 1,347 0.0058
2025-05-13 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,627 -734 -6.46 1,359 -9.52 0.0068
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,361 -5,994 -34.54 1,502 -40.54 0.0072
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,355 -1,851 -9.64 2,527 -4.17 0.0097
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 19,206 3,426 21.71 2,636 21.76 0.0111
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,780 169 1.08 2,165 2.12 0.0104
2024-02-14 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,611 -953 -5.75 2,121 4.59 0.0127
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,564 -1,010 -5.75 2,028 -9.14 0.0078
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,574 7,711 78.18 2,231 75.26 0.0028
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,863 3,136 46.62 1,274 122.16 0.0255
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,727 -419 -5.86 574 -31.54 0.0073
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,146 407 6.04 837 5.55 0.0106
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,739 3,547 111.12 793 90.63 0.0097
2022-05-16 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,192 -965 -23.21 416 -34.38 0.0043
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,157 2,698 184.92 634 168.64 0.0061
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,459 150 11.46 236 10.28 0.0032
2021-08-10 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,309 -1,149 -46.75 214 -42.16 0.0030
2021-05-12 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,458 235 10.57 370 9.79 0.0059
2021-02-11 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,223 455 25.74 337 40.42 0.0055
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,768 1,768 240 0.0045
2019-08-20 2019-06-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 0 -226 -100.00 0 -100.00
2019-05-15 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 226 76 50.67 25 78.57 0.0010
2019-05-21 2018-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 150 150 14 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.